Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

HRTX

Heron Therapeutics Inc

May 08 • 04:00PM ET

3.01

Dollar change +0.14
Percentage change 4.88	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO SCHA VTWO VHT ITOT IWC FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.62	Insider Own	5.10%	Shs Outstand	150.29M	Perf Week	28.63%
Market Cap	453.43M	Forward P/E	301.00	EPS next Y	0.01	Insider Trans	4.20%	Shs Float	142.96M	Perf Month	7.50%
Income	-80.95M	PEG	-	EPS next Q	-0.04	Inst Own	71.14%	Short Float	17.79%	Perf Quarter	33.19%
Sales	132.10M	P/S	3.43	EPS this Y	86.25%	Inst Trans	7.17%	Short Ratio	10.62	Perf Half Y	306.76%
Book/sh	-0.22	P/B	-	EPS next Y	109.09%	ROA	-36.90%	Short Interest	25.43M	Perf Year	23.36%
Cash/sh	0.47	P/C	6.34	EPS next 5Y	47.50%	ROE	-2408.88%	52W Range	0.50 - 3.22	Perf YTD	77.06%
Dividend Est.	-	P/FCF	-	EPS past 5Y	20.01%	ROI	-56.90%	52W High	-6.52%	Beta	1.73
Dividend TTM	-	Quick Ratio	1.90	Sales past 5Y	17.85%	Gross Margin	57.08%	52W Low	502.00%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	2.47	EPS Y/Y TTM	54.94%	Oper. Margin	-62.34%	RSI (14)	61.89	Volatility	10.83% 8.69%
Employees	126	Debt/Eq	-	Sales Y/Y TTM	16.05%	Profit Margin	-61.28%	Recom	1.25	Target Price	6.75
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	92.39%	Payout	-	Rel Volume	1.65	Prev Close	2.87
Sales Surprise	5.13%	EPS Surprise	73.15%	Sales Q/Q	17.07%	Earnings	May 07 BMO	Avg Volume	2.39M	Price	3.01
SMA20	12.21%	SMA50	10.73%	SMA200	64.30%	Trades		Volume	3,887,357	Change	4.88%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Initiated	CapitalOne	Overweight	$6
Mar-13-24	Reiterated	Needham	Buy	$4 → $5
May-27-20	Initiated	Guggenheim	Buy	$24
Feb-20-20	Reiterated	Needham	Buy	$50 → $48
Jan-16-19	Reiterated	Needham	Buy	$66 → $64
Apr-05-18	Initiated	Evercore ISI	Outperform	$56
Mar-19-18	Reiterated	Mizuho	Buy	$28 → $35
Mar-01-18	Reiterated	Needham	Buy	$28 → $30
Jan-03-18	Initiated	Leerink Partners	Outperform	$22
Sep-27-17	Initiated	Northland Capital	Outperform	$40
Feb-27-17	Initiated	Needham	Buy	$28
Oct-26-16	Initiated	Aegis Capital	Buy
Sep-06-16	Resumed	Lake Street	Buy	$45
May-03-16	Initiated	Cantor Fitzgerald	Buy
Dec-10-15	Initiated	Lake Street	Buy	$45
Sep-23-15	Reiterated	Leerink Partners	Outperform	$38 → $57
Sep-02-15	Initiated	BofA/Merrill	Buy	$46
Aug-03-15	Reiterated	Brean Capital	Buy	$40 → $45
Jun-30-15	Reiterated	JMP Securities	Mkt Outperform	$25 → $33
Jun-19-15	Reiterated	Leerink Partners	Outperform	$26 → $38

Show Previous Ratings

May-08-24 12:30PM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ... (GuruFocus.com)
May-07-24 12:54PM	HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:34AM	Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates (GuruFocus.com)
09:30AM	Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
09:05AM	Loading…
09:05AM	Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:06AM	Heron Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
Apr-30-24 10:01AM	Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know (Zacks) -7.20%
Apr-24-24 08:00AM	Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 (PR Newswire) -5.36%
Apr-11-24 04:05PM	Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City (PR Newswire) +7.69%
Mar-28-24 04:05PM	Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-13-24 09:19AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript (Insider Monkey) +27.54%
07:04AM	Q4 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-12-24 06:00PM	Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics (Zacks)
05:33PM	Loading…
05:33PM	Heron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023 (GuruFocus.com)
04:34PM	Heron Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
Mar-07-24 09:15AM	Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Feb-28-24 08:00AM	Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024 (PR Newswire)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
Feb-06-24 12:00PM	All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buy (Zacks)
Jan-25-24 06:44AM	Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion (Zacks)
Jan-24-24 01:47PM	Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod (Benzinga) +18.86%
Jan-23-24 08:00PM	Heron Therapeutics Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures (PR Newswire) -5.98%
Jan-15-24 04:51PM	The 3 Most Undervalued Biotech Stocks to Buy in January (InvestorPlace)
09:55AM	Heron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jan-07-24 05:00PM	Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain (PR Newswire)
Dec-10-23 12:23PM	Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master (Associated Press Finance)
Dec-06-23 11:55AM	13 Hot Penny Stocks To Buy According to Hedge Funds (Insider Monkey)
07:33PM	Loading…
Nov-28-23 07:33PM	Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth (InvestorPlace) -7.95%
Nov-15-23 10:17AM	Heron Therapeutics Inc (HRTX) Raises 2023 Sales Guidance and Projects Positive EBITDA in 2024 (GuruFocus.com) +59.26%
08:51AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:46AM	Q3 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-14-23 06:00PM	Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:17PM	Heron Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance (PR Newswire)
Nov-07-23 04:05PM	Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023 (PR Newswire) +6.88%
Aug-24-23 09:29AM	11 Best Long-Term Penny Stocks to Buy Now (Insider Monkey)
Aug-15-23 01:30PM	Heron Therapeutics (HRTX) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +10.93%
12:48PM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript (Insider Monkey)
09:47AM	Q2 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:29PM	Heron Therapeutics: Q2 Earnings Snapshot (Associated Press Finance) -6.79%
04:05PM	Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates (PR Newswire)
Aug-07-23 04:05PM	Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (PR Newswire)
10:50AM	Insiders Pour Millions Into These 2 Stocks Under $10 Heres Why Wall Street Thinks They Could Double (or More) (TipRanks)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE) +9.27%
Jul-24-23 09:02AM	Heron Therapeutics Announces Cost Reduction Plan and Restructuring (PR Newswire) +11.59%
09:00AM	Heron Therapeutics Announces $30 Million Private Placement Financing (PR Newswire)
Jun-23-23 04:05PM	Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer (PR Newswire)
Jun-12-23 09:00AM	Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer (PR Newswire)
May-11-23 05:15PM	Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -8.98%
04:12PM	Heron Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:01PM	Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates (PR Newswire)
May-05-23 12:28PM	Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel (Simply Wall St.)
Apr-20-23 11:45AM	These 2 Growth Stocks Might Be Incredibly Undervalued Right Now (Motley Fool) -5.56%
09:00AM	Heron Therapeutics Announces Commercial Leadership Changes (PR Newswire)
Apr-17-23 04:05PM	Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference (PR Newswire) +5.13%
Apr-06-23 03:42PM	Why Heron Therapeutics Stock Has Been on Fire This Week (Motley Fool) +20.00%
02:01PM	Why Shares of Heron Therapeutics Jumped Thursday (Motley Fool)
Apr-03-23 09:00AM	Heron Therapeutics Announces New CEO and Board Chairman (PR Newswire) +17.88%
Mar-27-23 07:12AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2022 Earnings Call Transcript (Insider Monkey) -9.19%
Mar-24-23 06:43AM	Q4 2022 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -7.75%
Mar-23-23 09:28PM	Dow futures tick higher, banking crisis weighs (Investing.com)
05:35PM	Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Mar-13-23 09:00AM	Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE, Effective April 1, 2023 (PR Newswire) +11.11%
Mar-10-23 04:05PM	Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023 (PR Newswire) -5.68%
Mar-06-23 09:00AM	Heron Therapeutics Announces U.S. Commercial Launch of APONVIE for the Management of Postoperative Nausea and Vomiting in Adults (PR Newswire)
Feb-27-23 04:30PM	Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference (PR Newswire)
Feb-22-23 09:00AM	Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital (PR Newswire) +10.88%
Jan-30-23 05:54AM	The past three years for Heron Therapeutics (NASDAQ:HRTX) investors has not been profitable (Simply Wall St.)
Jan-09-23 08:30AM	Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises (PR Newswire)
Dec-29-22 09:45AM	Heron Therapeutics Files For Expanded Use Of Zynrelef In Soft Tissue, Orthopedic Surgical Procedures (Benzinga) +9.78%
09:00AM	Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF® and Provision in Newly Passed Congressional Bill Anticipated to Provide Separate Reimbursement Outside of the Packaged Surgical Payment for ZYNRELEF (PR Newswire)
Dec-28-22 12:32PM	15 Most Shorted Stocks Hedge Funds Are Buying (Insider Monkey)
Dec-20-22 03:41PM	12 Best Affordable Stocks to Buy Under $5 (Insider Monkey)
Nov-21-22 04:05PM	Heron Therapeutics Announces Virtual Presentation at Evercore ISI 5th Annual HealthCONx Conference (PR Newswire)
Nov-15-22 10:14PM	7 Penny Stocks to Buy for 10-Bagger Returns (InvestorPlace)
Nov-10-22 05:44AM	Heron Therapeutics Third Quarter 2022 Earnings: In Line With Expectations (Simply Wall St.)
Nov-09-22 01:15PM	Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3 (Benzinga) -12.75%
Nov-08-22 06:25PM	Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Nov-04-22 11:48AM	Hurry! 7 Pitiful Stocks to Sell Before 2022 Ends (InvestorPlace)
Nov-01-22 04:05PM	Heron Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 (PR Newswire)
Sep-26-22 09:45AM	4 No-Brainer Penny Stocks to Buy if You Have Money to Invest (InvestorPlace)
Sep-23-22 09:19AM	10 Most Shorted Stocks in September (Insider Monkey) -7.66%
07:30AM	7 Unknown Biotech Stocks That Could Rocket in 2023 (InvestorPlace)
Sep-19-22 06:42AM	FDA Approves Heron Therapeutics' Post-Op Nausea Treatment (Benzinga)
Sep-16-22 02:49PM	Heron Therapeutics Announces U.S. FDA Approval of APONVIE (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV) (PR Newswire)
Sep-12-22 07:37AM	3 Stocks Expecting Good News From the FDA (Motley Fool)
Aug-23-22 12:00PM	All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Buy (Zacks)
Aug-15-22 09:55AM	How Much Upside is Left in Heron Therapeutics (HRTX)? Wall Street Analysts Think 91% (Zacks)
Aug-09-22 02:10PM	Heron Shares Jump After Equity Financing, Q2 Earnings (Benzinga) +15.13%
09:15AM	Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:01AM	Heron Therapeutics Announces $76.5 Million Private Placement Financing (PR Newswire)
08:00AM	Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Highlights Recent Corporate Updates (PR Newswire)
Aug-02-22 04:05PM	Heron Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 (PR Newswire)
Jul-21-22 06:32AM	Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Jul-18-22 06:00PM	7 Biotech Stocks to Buy for Q3 (InvestorPlace)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Forbes William P	EVP, Chief Development Officer	Nov 17 '23	Buy	1.09	25,000	27,250	79,000	Nov 21 12:19 PM
Collard Craig A	Chief Executive Officer	Nov 16 '23	Buy	0.92	150,000	137,970	186,496	Nov 17 12:37 PM
Duarte Ira	EVP, Chief Financial Officer	Nov 16 '23	Buy	0.89	85,000	75,599	85,000	Nov 17 12:36 PM
Forbes William P	EVP, Chief Development Officer	Nov 16 '23	Buy	0.94	50,000	46,995	54,000	Nov 20 10:07 AM
Morgan Adam	Director	Jul 21 '23	Buy	1.37	2,486,744	3,406,839	6,986,744	Jul 25 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRTX

Heron Therapeutics Inc

Upgrade your FINVIZ experience